Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response
  • Myriapod

KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population

  • Response

Francesca Spada et. al., Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis

  • Easy, Myriapod

Umberto Malapelle et. al., Predictive molecular pathology in the time of coronavirus disease

  • Myriapod NGS

Moira Ragazzi et. al., Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature

  • Myriapod NGS, Response

Francesca Consoli et. al., A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report

  • Easy PGX

Jessica Lucchetti et. al., Value of liquid biopsy using high-affinity plasma DNA binding magnetic beads and qualitative real-time PCR for KRAS, NRAS and BRAF mutations in metastatic colorectal cancer patients

  • Myriapod

Marco Mammana et. al., Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis

  • Easy PGX

Claudia Rengucci et. al., Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

  • Myriapod NGS

Alberto Pavan et. al., Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.

  • Easy, Myriapod

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Your next step starts here. Fill out the form and talk to us

Let's talk